Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients
Egle Corrado, Giuseppe Dattilo, Giuseppe Coppola, Claudia Morabito, Enrico Bonnì, Luca Zappia, Giuseppina Novo, Cesare de Gregorio
Topics & Concepts
MedicineEjection fractionSacubitrilHeart failureValsartanTolerabilityInternal medicineObservational studySacubitril, ValsartanCardiologyCardiac function curveDosingBlood pressurePopulationAdverse effectEnvironmental healthHeart Failure Treatment and ManagementCardiovascular Function and Risk FactorsCardiovascular and exercise physiology